In the past month, the US government has invested billions of dollars into the pandemic.Think $2.7 billion toward vaccine manufacturing, which is part of the $65 billion decade-long proposal the Biden administration created to prepare for future pandemics.
Or consider the $2 billion it paid for more COVID-19 rapid tests, or the roughly $3 billion worth of monoclonal antibodies it bought in mid-September on top of prior purchases.As the pandemic has shown, though, increased financial support doesn't mean manufacturing lines can suddenly produce a greater volume.
That's why the general public and healthcare workers are dealing with high demand for both monoclonal antibody treatments and COVID-19 rapid tests, and the federal government is